ARTICLE
26 April 2022

Jennifer Kreick Co-Authors American Health Law Association Article On Regulatory Diligence For Digital Health Transactions

HB
Haynes and Boone

Contributor

Haynes Boone is among the fastest-growing firms in the Am Law 100, providing full-service counsel across sectors, including corporate, energy, financial services, real estate, restructuring, litigation, intellectual property and specialty transactions. The firm represents companies at all stages – many in the Fortune 500 and S&P 500 and hundreds that are well-funded, exchange-listed, privately held and/or in emerging-growth mode. Nearly 700 lawyers practice across 19 global offices in California, Colorado, Illinois, New York, North Carolina, Texas, Virginia, Washington, D.C., London, Mexico City and Shanghai. In 2024, Chambers USA ranked 35 firm practice areas, and Haynes Boone became the first Am Law 100 firm to earn Mental Health America’s Gold Bell Seal for its industry-leading commitment to creating a mentally healthy workplace.

Jennifer Kreick, a partner in Haynes Boone's Healthcare and Life Sciences Practice, collaborated on an article for the American Health Law Association with a team of lawyers from multiple law firms.
United States Food, Drugs, Healthcare, Life Sciences

Jennifer Kreick, a partner in Haynes Boone's Healthcare and Life Sciences Practice, collaborated on an article for the American Health Law Association with a team of lawyers from multiple law firms. Read an excerpt below:

The digital health technology marketplace is booming, spawning a multitude of investment opportunities and a steadily growing volume of digital health transactions. Given the complex regulatory landscape surrounding these transactions, appropriate diligence is key to protecting investors. Digital health encompasses a broad array of technologies, including telehealth, mobile health applications, diagnostic tools and technology, electronic health records (EHR), wearables, remote patient monitoring, and many others. The variety of digital health technologies can make diligence challenging because of the varied health care regulations that can be implicated by different technologies. This Briefing outlines some of the potential healthcare regulatory considerations for a digital health transaction and includes tools, such as a sample diligence checklist, for these transactions.

Excerpted from an American Health Law Association Briefing. To read the full article, click  here.

Originally Published by American Health Law Association

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More